Skip to content
777 Sourcing.

Capability

regenerative therapy research

Suppliers
1
States & provinces
1
Countries
1

1 regenerative therapy research supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

CAEREGEN THERAPEUTICS LLC

TROY, MI

RetiNova Therapeutics is developing a new class of regenerative therapies designed to reverse vision loss associated with retinal ischemia. Its Noregen™ (CTR-107) program, a synthetic protein modeled after norrin, is in late preclinical development for diabetic macular edema (DME) and retinal vein occlusion (RVO), aiming for disease modification and regeneration of functional retinal tissue.

preclinical drug development

Compiled from public sources

Related capabilities

Other processes offered by the shops that list regenerative therapy research.

Browse all capabilities